Works by Barr, Paul M.

Results: 70

Follicular Lymphoma: Recent and Emerging Therapies, Treatment Strategies, and Remaining Unmet Needs.

Published in:

Oncologist, 2019, v. 24, n. 11, p. e1236, doi. 10.1634/theoncologist.2019-0138

By:

Matasar, Matthew J.;
Luminari, Stefano;
Barr, Paul M.;
Barta, Stefan K.;
Danilov, Alexey V.;
Hill, Brian T.;
Phillips, Tycel J.;
Jerkeman, Mats;
Magagnoli, Massimo;
Nastoupil, Loretta J.;
Persky, Daniel O.;
Okosun, Jessica

Publication type:

Article

Pitfalls of Combining Novel Agents in Lymphoma.

Published in:

2018

By:

Rodgers, Thomas D.;
Barr, Paul M.

Publication type:

journal article

Treatment of Relapsed/Refractory CLL Patients With PI3Kδ Inhibitor and Anti‐CD20 Antibody Rapidly Decreases Tumor Burden but Could Induce Resistance.

Published in:

American Journal of Hematology, 2025, v. 100, n. 3, p. 523, doi. 10.1002/ajh.27569

By:

Bruno, Jennifer E.;
Herne, Christine A.;
Baran, Andrea M.;
VanDerMeid, Karl R.;
Barr, Paul M.;
Williams, Alyssa R.;
Quataert, Sally A.;
Mosmann, Tim R.;
Zent, Clive S.;
Chu, Charles C.

Publication type:

Article

Treatment Effectiveness of Venetoclax‐Based Therapy After Bruton Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia: An International Real‐World Study.

Published in:

American Journal of Hematology, 2025, v. 100, n. 3, p. 511, doi. 10.1002/ajh.27563

By:

Ghosh, Nilanjan;
Eyre, Toby A.;
Brown, Jennifer R.;
Lamanna, Nicole;
Manzoor, Beenish S.;
Coombs, Catherine C.;
Tuncer, Hande H.;
Ujjani, Chaitra;
Leslie, Lori A.;
Roeker, Lindsey E.;
Davids, Matthew S.;
Rhodes, Joanna M.;
Skarbnik, Alan P.;
Sinai, Wendy;
Fleury, Isabelle;
Hill, Brian T.;
Martinez‐Calle, Nicolas;
Barr, Paul M.;
Jawaid, Dureshahwar;
Emechebe, Nnadozie

Publication type:

Article

Initial treatment of B‐cell prolymphocytic leukemia with ibrutinib.

Published in:

American Journal of Hematology, 2020, v. 95, n. 5, p. E108, doi. 10.1002/ajh.25733

By:

Moore, Jeremiah;
Baran, Andrea M.;
Meacham, Philip J.;
Evans, Andrew G.;
Barr, Paul M.;
Zent, Clive S.

Publication type:

Article

Significant weight gain in CLL patients treated with Ibrutinib: A potentially deleterious consequence of therapy.

Published in:

American Journal of Hematology, 2020, v. 95, n. 1, p. E16, doi. 10.1002/ajh.25663

By:

Williams, AnnaLynn M.;
Baran, Andrea M.;
Schaffer, Mahlon;
Bushart, Jocelyn;
Rich, Lynn;
Moore, Jeremiah;
Barr, Paul M.;
Zent, Clive S.

Publication type:

Article

Final analysis from RESONATE: Up to six years of follow‐up on ibrutinib in patients with previously treated chronic lymphocytic leukemia or small lymphocytic lymphoma.

Published in:

American Journal of Hematology, 2019, v. 94, n. 12, p. 1353, doi. 10.1002/ajh.25638

By:

Munir, Talha;
Brown, Jennifer R.;
O'Brien, Susan;
Barrientos, Jacqueline C.;
Barr, Paul M.;
Reddy, Nishitha M.;
Coutre, Steven;
Tam, Constantine S.;
Mulligan, Stephen P.;
Jaeger, Ulrich;
Kipps, Thomas J.;
Moreno, Carol;
Montillo, Marco;
Burger, Jan A.;
Byrd, John C.;
Hillmen, Peter;
Dai, Sandra;
Szoke, Anita;
Dean, James P.;
Woyach, Jennifer A.

Publication type:

Article

Outcomes with ibrutinib by line of therapy and post‐ibrutinib discontinuation in patients with chronic lymphocytic leukemia: Phase 3 analysis.

Published in:

American Journal of Hematology, 2019, v. 94, n. 5, p. 554, doi. 10.1002/ajh.25436

By:

O'Brien, Susan M.;
Byrd, John C.;
Hillmen, Peter;
Coutre, Steven;
Brown, Jennifer R.;
Barr, Paul M.;
Barrientos, Jacqueline C.;
Devereux, Stephen;
Robak, Tadeusz;
Reddy, Nishitha M.;
Kipps, Thomas J.;
Tedeschi, Alessandra;
Cymbalista, Florence;
Ghia, Paolo;
Chang, Stephen;
Ninomoto, Joi;
James, Danelle F.;
Burger, Jan A.

Publication type:

Article

Outcomes of front‐line ibrutinib treated CLL patients excluded from landmark clinical trial.

Published in:

American Journal of Hematology, 2018, v. 93, n. 11, p. 1394, doi. 10.1002/ajh.25261

By:

Mato, Anthony R.;
Roeker, Lindsey E.;
Allan, John N.;
Pagel, John M.;
Brander, Danielle M.;
Hill, Brian T.;
Cheson, Bruce D.;
Furman, Richard R.;
Lamanna, Nicole;
Tam, Constantine S.;
Handunnetti, Sasanka;
Jacobs, Ryan;
Lansigan, Frederick;
Bhavsar, Erica;
Barr, Paul M.;
Shadman, Mazyar;
Skarbnik, Alan P.;
Goy, Andre;
Beach, Douglas F.;
Svoboda, Jakub

Publication type:

Article

Single‐agent ibrutinib versus chemoimmunotherapy regimens for treatment‐naïve patients with chronic lymphocytic leukemia: A cross‐trial comparison of phase 3 studies.

Published in:

American Journal of Hematology, 2018, v. 93, n. 11, p. 1402, doi. 10.1002/ajh.25259

By:

Robak, Tadeusz;
Burger, Jan A.;
Tedeschi, Alessandra;
Barr, Paul M.;
Owen, Carolyn;
Bairey, Osnat;
Hillmen, Peter;
Simpson, David;
Grosicki, Sebastian;
Devereux, Stephen;
McCarthy, Helen;
Coutre, Steven E.;
Quach, Hang;
Gaidano, Gianluca;
Maslyak, Zvenyslava;
Stevens, Don A.;
Moreno, Carol;
Gill, Devinder S.;
Flinn, Ian W.;
Gribben, John G.

Publication type:

Article

A phase I/II trial of vorinostat (SAHA) in combination with rituximab‐CHOP in patients with newly diagnosed advanced stage diffuse large B‐cell lymphoma (DLBCL): SWOG S0806.

Published in:

American Journal of Hematology, 2018, v. 93, n. 4, p. 486, doi. 10.1002/ajh.25010

By:

Persky, Daniel O.;
Li, Hongli;
Rimsza, Lisa M.;
Barr, Paul M.;
Popplewell, Leslie L.;
Bane, Charles L.;
Von Gehr, Ann;
LeBlanc, Michael;
Fisher, Richard I.;
Smith, Sonali M.;
Friedberg, Jonathan W.

Publication type:

Article

Phase II study of bryostatin 1 and vincristine for aggressive non-Hodgkin lymphoma relapsing after an autologous stem cell transplant.

Published in:

American Journal of Hematology, 2009, v. 84, n. 8, p. 484, doi. 10.1002/ajh.21449

By:

Barr, Paul M.;
Lazarus, Hillard M.;
Cooper, Brenda W.;
Schluchter, Mark D.;
Panneerselvam, Ashok;
Jacobberger, James W.;
Hsu, Jack W.;
Janakiraman, Nalini;
Simic, Aleksandra;
Dowlati, Afshin;
Remick, Scot C.

Publication type:

Article

Efficacy of bendamustine and rituximab in unfit patients with previously untreated chronic lymphocytic leukemia. Indirect comparison with ibrutinib in a real‐world setting. A GIMEMA‐ERIC and US study.

Published in:

Cancer Medicine, 2020, v. 9, n. 22, p. 8468, doi. 10.1002/cam4.3470

By:

Cuneo, Antonio;
Mato, Anthony R.;
Rigolin, Gian Matteo;
Piciocchi, Alfonso;
Gentile, Massimo;
Laurenti, Luca;
Allan, John N.;
Pagel, John M.;
Brander, Danielle M.;
Hill, Brian T.;
Winter, Allison;
Lamanna, Nicole;
Tam, Constantine S.;
Jacobs, Ryan;
Lansigan, Frederick;
Barr, Paul M.;
Shadman, Mazyar;
Skarbnik, Alan P.;
Pu, Jeffrey J.;
Sehgal, Alison R.

Publication type:

Article

Outpatient administration of BEAM conditioning prior to autologous stem cell transplantation for lymphoma is safe, feasible, and cost-effective.

Published in:

Cancer Medicine, 2016, v. 5, n. 11, p. 3059, doi. 10.1002/cam4.879

By:

Reid, Robin M.;
Baran, Andrea;
Friedberg, Jonathan W.;
Phillips, Gordon L.;
Liesveld, Jane L.;
Becker, Michael W.;
Wedow, Lucy;
Barr, Paul M.;
Milner, Laurie A.

Publication type:

Article

Getting to the heart of the problem in treating diffuse large B-cell lymphoma.

Published in:

Leukemia & Lymphoma, 2011, v. 52, n. 7, p. 1166, doi. 10.3109/10428194.2011.577260

By:

Barr, Paul M.;
Friedberg, Jonathan W.

Publication type:

Article

First‐line ibrutinib treatment in patients with chronic lymphocytic leukemia is associated with overall survival rates similar to those of an age‐matched general population: A pooled post hoc analysis.

Published in:

HemaSphere, 2024, v. 8, n. 5, p. 1, doi. 10.1002/hem3.74

By:

Ghia, Paolo;
Owen, Carolyn;
Allan, John N.;
Barrientos, Jacqueline C.;
Barr, Paul M.;
Shi, Chunxue;
Szoke, Anita;
Abbazio, Christopher;
Krigsfeld, Gabriel S.;
Burger, Jan A.

Publication type:

Article

P1200: ZILOVERTAMAB VEDOTIN (MK‐2140) IN RELAPSED OR REFRACTORY (R/R) NON‐HODGKIN LYMPHOMA (NHL): UPDATED RESULTS FROM THE PHASE 1 WAVELINE‐001 STUDY.

Published in:

HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000971696.54506.b2

By:

Spurgeon, Stephen;
Mei, Matthew;
Barr, Paul M.;
Barrientos, Jacqueline;
de Vos, Sven;
Furman, Richard;
Patel, Krish;
Thompson, Philip;
Choi, Michael Y.;
Kallam, Avyakta;
Wang, Siruo;
Ogbu, Uzor;
Marinello, Patricia;
Wang, Michael

Publication type:

Article

P647: RACIAL DISPARITIES IN REAL‐WORLD TREATMENT PATTERNS AND OUTCOMES AMONG PATIENTS WITH CLL.

Published in:

HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000969492.96103.aa

By:

Rhodes, Joanna;
Shadman, Mazyar;
Lamanna, Nicole;
S. Manzoor, Beenish;
Coombs, Catherine;
Ghosh, Nilanjan;
H. Tuncer, Hande;
Emechebe, Dozie;
R. Brown, Jennifer;
Alhasani, Hasan;
Leslie, Lori;
Roeker, Lindsey;
Ujjani, Chaitra;
Eichhorst, Barbara;
Fleury, Isabelle;
Skarbnik, Alan;
T. Hill, Brian;
Lansigan, Frederick;
M. Barr, Paul;
Davids, Matthew

Publication type:

Article

P648: REAL‐WORLD TREATMENT AND OUTCOMES OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) RECEIVING FIRST‐LINE (1L) THERAPY IN THE NOVEL AGENT ERA: AN INTERNATIONAL STUDY.

Published in:

HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000969496.68553.26

By:

Lansigan, Frederick;
A. Eyre, Toby;
Ghosh, Nilanjan;
S. Manzoor, Beenish;
C. Coombs, Catherine;
Lamanna, Nicole;
H. Tuncer, Hande;
Emechebe, Dozie;
R. Brown, Jennifer;
E. Roeker, Lindsey;
Ujjani, Chaitra;
Alhasani, Hasan;
Fleury, Isabelle;
A. Leslie, Lori;
Skarbnik, Alan;
Rhodes, Joanna;
T. Hill, Brian;
M. Barr, Paul;
S. Davids, Matthew;
P. Fox, Christopher

Publication type:

Article

P627: LONG-TERM OUTCOMES WITH CONTINUOUS IBRUTINIB IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA: ANALYSIS OF TIME TO PROGRESSION.

Published in:

2023

By:

Kipps, Thomas;
Owen, Carolyn;
W. Flinn, Ian;
M. Barr, Paul;
Tedeschi, Alessandra;
Greil, Richard;
Szafer-Glusman, Edith;
Huang, Hsin-Hui;
Neumayr, Lynne;
Abbazio, Chris;
Shanafelt, Tait

Publication type:

Abstract

P617: FIXED-DURATION (FD) IBRUTINIB + VENETOCLAX FOR FIRST-LINE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)/SMALL LYMPHOCYTIC LYMPHOMA (SLL): 4-Y FOLLOW-UP FROM FD COHORT OF PHASE 2 CAPTIVATE STUDY.

Published in:

2023

By:

Ghia, Paolo;
Allan, John;
Siddiqi, Tanya;
Wierda, William G.;
Tam, Constantine;
Moreno, Carol;
Tedeschi, Alessandra;
Szafer-Glusman, Edith;
Zhou, Cathy;
Abbazio, Chris;
Dean, Jim;
Szoke, Anita;
Barr, Paul M.

Publication type:

Abstract

Phase 2 trial of umbralisib, ublituximab, and venetoclax in patients with relapsed/refractory mantle cell lymphoma.

Published in:

Leukemia & Lymphoma, 2023, v. 64, n. 9, p. 1579, doi. 10.1080/10428194.2023.2223743

By:

Wallace, Danielle S.;
Rowland, Chris;
Hill, Brian T.;
Baran, Andrea M.;
Casulo, Carla;
Reagan, Patrick M.;
Winter, Allison;
Karmali, Reem;
Winter, Jane N.;
Gordon, Leo I.;
Bui, Andrew;
Sportelli, Peter;
Miskin, Hari P.;
Weiss, Michael S.;
Friedberg, Jonathan W.;
Ma, Shuo;
Barr, Paul M.

Publication type:

Article

Phase 1/2 study of acalabrutinib and the PI3K delta inhibitor ACP-319 in relapsed/refractory B-cell Non-Hodgkin lymphoma.

Published in:

Leukemia & Lymphoma, 2022, v. 63, n. 7, p. 1728, doi. 10.1080/10428194.2022.2043301

By:

Barr, Paul M.;
Smith, Stephen D.;
Roschewski, Mark J.;
O'Brien, Susan M.;
Sharman, Jeff P.;
Melear, Jason M.;
Patel, Priti;
Calvo, Roser;
Yang, Helen;
Spurgeon, Stephen E.

Publication type:

Article

Characterization of low-grade arthralgia, myalgia, and musculoskeletal pain with ibrutinib therapy: pooled analysis of clinical trials in patients with chronic lymphocytic leukemia and mantle cell lymphoma.

Published in:

Leukemia & Lymphoma, 2022, v. 63, n. 7, p. 1580, doi. 10.1080/10428194.2022.2038372

By:

Siddiqi, Tanya;
Coutre, Steven;
McKinney, Matthew;
Barr, Paul M.;
Rogers, Kerry;
Mokatrin, Ahmad;
Valentino, Rudy;
Szoke, Anita;
Deshpande, Sanjay;
Zhu, Angeline;
Arango-Hisijara, Israel;
Osei-Bonsu, Kojo;
Wang, Michael;
O'Brien, Susan

Publication type:

Article

Using ibrutinib in earlier lines of treatment results in better outcomes for patients with chronic lymphocytic leukemia/small lymphocytic lymphoma.

Published in:

2021

By:

Woyach, Jennifer;
Tedeschi, Alessandra;
Munir, Talha;
Siddiqi, Tanya;
Hillmen, Peter;
Byrd, John C.;
Ghia, Paolo;
Mulligan, Stephen P.;
Dai, Sandra;
Amaya-Chanaga, Carlos I.;
Dean, James P.;
O'Brien, Susan M.;
Barr, Paul M.

Publication type:

Letter

Toxicity patterns of novel PI3K combinations in patients with non-Hodgkin lymphoma.

Published in:

Leukemia & Lymphoma, 2021, v. 62, n. 3, p. 598, doi. 10.1080/10428194.2020.1837796

By:

Rodgers, Thomas D.;
Williams, AnnaLynn M.;
Baran, Andrea;
Reagan, Patrick M.;
Casulo, Carla;
Zent, Clive S.;
Evans, Andrew;
Friedberg, Jonathan W.;
Barr, Paul M.

Publication type:

Article

Additional B-cell malignancies in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL).

Published in:

Leukemia & Lymphoma, 2020, v. 61, n. 7, p. 1636, doi. 10.1080/10428194.2020.1737690

By:

Meacham, Philip J.;
Williams, AnnaLynn M.;
Strawderman, Myla;
Baran, Andrea M.;
Archibald, William J.;
Wallace, Danielle S.;
Tschernia, Nicholas P.;
Burack, Walter Richard;
Barr, Paul M.;
Zent, Clive S.

Publication type:

Article

Cognitive function in patients with chronic lymphocytic leukemia: a cross-sectional study examining effects of disease and treatment.

Published in:

Leukemia & Lymphoma, 2020, v. 61, n. 7, p. 1627, doi. 10.1080/10428194.2020.1728748

By:

Williams, AnnaLynn M.;
van Wijngaarden, Edwin;
Seplaki, Christopher L.;
Heckler, Charles E.;
Weber, Miriam T.;
Barr, Paul M.;
Zent, Clive S.;
Janelsins, Michelle C.

Publication type:

Article

Patients with diffuse large B-cell lymphoma requiring urgent treatment: its implication on trial design and interpretation.

Published in:

2019

By:

Loh, Kah Poh;
Baran, Andrea;
Lee, Christina Y.;
Alshaibani, Alfadel;
Rutherford, Sarah C.;
Hu, John;
Casulo, Carla;
Barr, Paul M.;
Friedberg, Jonathan W.;
Reagan, Patrick M.

Publication type:

Letter

Analysis of the risk of infection in patients with chronic lymphocytic leukemia in the era of novel therapies.

Published in:

Leukemia & Lymphoma, 2018, v. 59, n. 3, p. 625, doi. 10.1080/10428194.2017.1347931

By:

Williams, AnnaLynn M.;
Baran, Andrea M.;
Meacham, Philip J.;
Feldman, Megan M.;
Valencia, Hugo E.;
Newsom-Stewart, Catherine;
Gupta, Nealansh;
Janelsins, Michelle C.;
Barr, Paul M.;
Zent, Clive S.

Publication type:

Article

Phase 1 trial of carfilzomib (PR-171) in combination with vorinostat (SAHA) in patients with relapsed or refractory B-cell lymphomas.

Published in:

Leukemia & Lymphoma, 2016, v. 57, n. 3, p. 635, doi. 10.3109/10428194.2015.1075019

By:

Holkova, Beata;
Kmieciak, Maciej;
Bose, Prithviraj;
Yazbeck, Victor Y.;
Barr, Paul M.;
Tombes, Mary Beth;
Shrader, Ellen;
Weir-Wiggins, Caryn;
Rollins, April D.;
Cebula, Erin M.;
Pierce, Emily;
Herr, Megan;
Sankala, Heidi;
Hogan, Kevin T.;
Wan, Wen;
Feng, Changyong;
Peterson, Derick R.;
Fisher, Richard I.;
Grant, Steven;
Friedberg, Jonathan W.

Publication type:

Article

Infection in chronic lymphocytic leukemia: parsimony has its limits.

Published in:

Leukemia & Lymphoma, 2014, v. 55, n. 12, p. 2683, doi. 10.3109/10428194.2014.917642

By:

Barr, Paul M.;
Zent, Clive S.

Publication type:

Article

The ABC of chronic lymphocytic leukemia: Etiology of cytopenias is important in staging and management.

Published in:

2014

By:

Barr, Paul M.;
Zent, Clive S.

Publication type:

Opinion

Phase I trial of fludarabine, bortezomib and rituximab for relapsed and refractory indolent and mantle cell non-Hodgkin lymphoma.

Published in:

British Journal of Haematology, 2009, v. 147, n. 1, p. 89, doi. 10.1111/j.1365-2141.2009.07836.x

By:

Barr, Paul M.;
Pingfu Fu;
Lazarus, Hillard M.;
Horvath, Nancy;
Gerson, Stanton L.;
Koc, Omer N.;
Bahlis, Nizar J.;
Snell, Michael R.;
Dowlati, Afshin;
Cooper, Brenda W.

Publication type:

Article

A phase 1 trial of SGN-CD70A in patients with CD70-positive diffuse large B cell lymphoma and mantle cell lymphoma.

Published in:

Investigational New Drugs, 2019, v. 37, n. 2, p. 297, doi. 10.1007/s10637-018-0655-0

By:

Phillips, Tycel;
Barr, Paul M.;
Park, Steven I.;
Kolibaba, Kathryn;
Caimi, Paolo F.;
Chhabra, Saurabh;
Kingsley, Edwin C.;
Boyd, Thomas;
Chen, Robert;
Carret, Anne-Sophie;
Gartner, Elaina M.;
Li, Hong;
Yu, Cindy;
Smith, David C.

Publication type:

Article

Highlights in Leukemia and Lymphoma From the 62nd American Society of Hematology Annual Meeting and Exposition: Commentary.

Published in:

Clinical Advances in Hematology & Oncology, 2021, v. 19, p. 17

By:

Barr, Paul M.

Publication type:

Article

Nursing Experience in Patients Receiving Long-Term Ibrutinib for Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): Final Analysis Results from Phase 3 RESONATE Study.

Published in:

Journal of Oncology Navigation & Survivorship, 2019, v. 10, n. 11, p. 505

By:

Settlemire, Jillian;
Bushart, Jocelyn E.;
Dai, Sandra;
Dean, James P.;
Arthur, David;
Barr, Paul M.;
Coutre, Steven

Publication type:

Article

Restoring Quality of Life and Hematologic Function with Ibrutinib in Treatment-Naive Patients with Chronic Lymphocytic Leukemia in the RESONATE-2 Study.

Published in:

Journal of Oncology Navigation & Survivorship, 2016, v. 7, n. 9, p. 58

By:

Deisinger, Sara;
Greenberg, Edythe;
Zhou, Cathy;
Styles, Lori;
James, Danelle;
Burger, Jan A.;
Barr, Paul M.

Publication type:

Article

Characteristics and Clinical Outcomes of Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Receiving Ibrutinib for ≥5 Years in the RESONATE-2 Study.

Published in:

Cancers, 2023, v. 15, n. 2, p. 507, doi. 10.3390/cancers15020507

By:

Woyach, Jennifer A.;
Barr, Paul M.;
Kipps, Thomas J.;
Barrientos, Jacqueline C.;
Ahn, Inhye E.;
Ghia, Paolo;
Girardi, Vincent;
Hsu, Emily;
Jermain, Mandy;
Burger, Jan A.

Publication type:

Article

Long-term safety experience with bendamustine for injection in a real-world setting.

Published in:

Expert Opinion on Drug Safety, 2017, v. 16, n. 6, p. 647, doi. 10.1080/14740338.2017.1318125

By:

Martin, Peter;
Barr, Paul M.;
James, Leonard;
Pathak, Ashutosh;
Kahl, Brad

Publication type:

Article

Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma.

Published in:

Nature Medicine, 2015, v. 21, n. 8, p. 922, doi. 10.1038/nm.3884

By:

Wilson, Wyndham H;
Young, Ryan M;
Schmitz, Roland;
Yang, Yandan;
Pittaluga, Stefania;
Wright, George;
Lih, Chih-Jian;
Williams, P Mickey;
Shaffer, Arthur L;
Gerecitano, John;
de Vos, Sven;
Goy, Andre;
Kenkre, Vaishalee P;
Barr, Paul M;
Blum, Kristie A;
Shustov, Andrei;
Advani, Ranjana;
Fowler, Nathan H;
Vose, Julie M;
Elstrom, Rebecca L

Publication type:

Article

The efficacy and safety of venetoclax therapy in elderly patients with relapsed, refractory chronic lymphocytic leukaemia.

Published in:

British Journal of Haematology, 2020, v. 188, n. 6, p. 918, doi. 10.1111/bjh.16271

By:

Eyre, Toby A.;
Roeker, Lindsey E.;
Fox, Christopher P.;
Gohill, Satyen H.;
Walewska, Renata;
Walter, Harriet S.;
Forconi, Francesco;
Broom, Angus;
Arumainathan, Arvind;
Brander, Danielle M.;
Allan, John N.;
Schuster, Stephen J.;
Hill, Brian T.;
Lansigan, Frederick;
Cheson, Bruce D.;
Lamanna, Nicole;
Coombs, Catherine C.;
Barr, Paul M.;
Skarbnik, Alan P.;
Shadman, Mazyar

Publication type:

Article

Efficacy of lenalidomide in high‐risk diffuse large B‐cell lymphoma.

Published in:

British Journal of Haematology, 2020, v. 188, n. 4, p. e33, doi. 10.1111/bjh.16302

By:

Rodgers, Thomas D.;
Baran, Andrea;
Reagan, Patrick M.;
Casulo, Carla;
Zent, Clive;
Evans, Andrew;
Burack, Richard;
Williams, AnnaLynn M.;
Friedberg, Jonathan W.;
Barr, Paul M.

Publication type:

Article

Multicentre retrospective study of intravascular large B‐cell lymphoma treated at academic institutions within the United States.

Published in:

British Journal of Haematology, 2019, v. 186, n. 2, p. 255, doi. 10.1111/bjh.15923

By:

Geer, Marcus;
Roberts, Emily;
Shango, Maryann;
Till, Brian G.;
Smith, Stephen D.;
Abbas, Hashim;
Hill, Brian T.;
Kaplan, Jason;
Barr, Paul M.;
Caimi, Paolo;
Stephens, Deborah M.;
Lin, Emily;
Herrera, Alex F.;
Rosenbaum, Evan;
Amengual, Jennifer E.;
Boonstra, Philip S.;
Devata, Sumana;
Wilcox, Ryan A.;
Kaminski, Mark S.;
Phillips, Tycel J.

Publication type:

Article

Tumour debulking and reduction in predicted risk of tumour lysis syndrome with single‐agent ibrutinib in patients with chronic lymphocytic leukaemia.

Published in:

British Journal of Haematology, 2019, v. 186, n. 1, p. 184, doi. 10.1111/bjh.15791

By:

Wierda, William G.;
Byrd, John C.;
O'Brien, Susan;
Coutre, Steven;
Barr, Paul M.;
Furman, Richard R.;
Kipps, Thomas J.;
Burger, Jan A.;
Stevens, Don A.;
Sharman, Jeff;
Ghia, Paolo;
Flinn, Ian W.;
Zhou, Cathy;
Ninomoto, Joi;
James, Danelle F.;
Tam, Constantine S.

Publication type:

Article

Ibrutinib provides favourable survival outcomes in patients with comorbidities versus established therapies.

Published in:

British Journal of Haematology, 2019, v. 186, n. 1, p. 175, doi. 10.1111/bjh.15784

By:

Burger, Jan A.;
Cramer, Paula;
Barr, Paul M.;
Dilhuydy, Marie‐Sarah;
Mato, Anthony;
Byrd, John C.;
Chang, Stephen;
Graef, Thorsten;
Lin, Tony;
Tedeschi, Alessandra

Publication type:

Article

Venetoclax for chronic lymphocytic leukaemia patients who progress after more than one B‐cell receptor pathway inhibitor.

Published in:

British Journal of Haematology, 2019, v. 185, n. 5, p. 961, doi. 10.1111/bjh.15666

By:

Wierda, William G.;
Byrd, John C.;
Davids, Matthew S.;
Furman, Richard R.;
Cheson, Bruce D.;
Barr, Paul M.;
Eradat, Herbert;
Heffner, Leonard;
Zhou, Lang;
Verdugo, Maria;
Potluri, Jalaja;
Choi, Michael

Publication type:

Article

Use of anticoagulants and antiplatelet in patients with chronic lymphocytic leukaemia treated with single-agent ibrutinib.

Published in:

British Journal of Haematology, 2017, v. 178, n. 2, p. 286, doi. 10.1111/bjh.14660

By:

Jones, Jeffrey A.;
Hillmen, Peter;
Coutre, Steven;
Tam, Constantine;
Furman, Richard R.;
Barr, Paul M.;
Schuster, Stephen J.;
Kipps, Thomas J.;
Flinn, Ian W.;
Jaeger, Ulrich;
Burger, Jan A.;
Cheng, Mei;
Ninomoto, Joi;
James, Danelle F.;
Byrd, John C.;
O'Brien, Susan M.

Publication type:

Article

RB but not R- HCVAD is a feasible induction regimen prior to auto- HCT in frontline MCL: results of SWOG Study S1106.

Published in:

British Journal of Haematology, 2017, v. 176, n. 5, p. 759, doi. 10.1111/bjh.14480

By:

Chen, Robert W.;
Li, Hongli;
Bernstein, Steven H.;
Kahwash, Samir;
Rimsza, Lisa M.;
Forman, Stephen J.;
Constine, Louis;
Shea, Thomas C.;
Cashen, Amanda F.;
Blum, Kristie A.;
Fenske, Timothy S.;
Barr, Paul M.;
Phillips, Tycel;
Leblanc, Michael;
Fisher, Richard I.;
Cheson, Bruce D.;
Smith, Sonali M.;
Faham, Malek;
Wilkins, Jennifer;
Leonard, John P.

Publication type:

Article

ALK‐rearranged CD30‐positive poorly differentiated lung adenocarcinoma, mimicking anaplastic large‐cell lymphoma.

Published in:

Histopathology, 2024, v. 84, n. 5, p. 900, doi. 10.1111/his.15105

By:

George, Giby V;
Wallace, Danielle S;
Wang, Ying;
Carney, John;
Elsadawi, Murad;
Burack, W Richard;
Evans, Andrew G;
Barr, Paul M;
Velez, Moises J;
El Hussein, Siba

Publication type:

Article